Green Cross' phase II studies for anti-osteoporosis drug successful.
Its pre-clinical and phase I study had been successfully made in England and the U. S. in conformance with the U. S. FDA. Now, it...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
